The efficacy and safety of short-acting, full agonist opioids for symptom management of opioid withdrawal
Introduction: Patients with opioid use disorder often have undertreated withdrawal while in hospital, leading to high rates of premature discharges. Short-acting, full agonist opioids (SAFAOs) have been proposed to alleviate withdrawal symptoms when provided as adjuncts to opioid agonist therapy (OA...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier
2026-06-01
|
| Colección: | Addictive Behaviors Reports |
| Acceso en línea: | http://www.sciencedirect.com/science/article/pii/S2352853226000271 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
